4//SEC Filing
Parison Amy 4
Accession 0001650664-25-000118
CIK 0001650664other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 4:28 PM ET
Size
4.9 KB
Accession
0001650664-25-000118
Insider Transaction Report
Form 4
Parison Amy
SVP, Chief Financial Officer
Transactions
- Sale
Common Stock
2025-08-07$2.58/sh−679$1,752→ 16,827 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 7, 2022, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 6, 2025. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0002063082
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 4:28 PM ET
- Size
- 4.9 KB